pentobarbital will reduce the extent or outcome of guanfacine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Sturdy or reasonable CYP3A4 inducers drastically lessen guanfacine plasma concentrations and elimination fifty percent-lifetime.pentobarbital will minimize the extent or outcome of itraconaz